Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas

被引：0
|
作者：
M T Rahman
K Nakayama
M Rahman
H Katagiri
A Katagiri
T Ishibashi
M Ishikawa
K Iida
N Nakayama
Y Otsuki
S Nakayama
K Miyazaki
机构：
[1] Shimane University School of Medicine,Departments of Obstetrics and Gynecology
[2] Shimane University School of Medicine,Department of Biocehmistory
[3] Seirei Hamamatsu General Hospital,Department of Pathology
[4] Seirei Hamamatsu General Hospital,Department of Obstetrics and Gynecology
来源：
British Journal of Cancer | 2012年 / 107卷
关键词：
ovarian clear cell carcinoma; fatty acid synthase; survival; NAC1; C75;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：300 / 307
页数：7
相关论文
共 50 条
  • [31] High Prevalence of Fatty Acid Synthase Expression in Colorectal Cancers in Middle Eastern Patients and Its Potential Role as a Therapeutic Target
    Uddin, Shahab
    Hussain, Azhar R.
    Ahmed, Maqbool
    Abubaker, Jehad
    Al-Sanea, Nasser
    AbdulJabbar, Alaa
    Ashari, Luai H.
    Alhomoud, Samar
    Al-Dayel, Fouad
    Bavi, Prashant
    Al-Kuraya, Khawla S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (07): : 1790 - 1801
  • [32] ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas
    Silva, S. D.
    Cunha, I. W.
    Younes, R. N.
    Soares, F. A.
    Kowalski, L. P.
    Graner, E.
    ORAL DISEASES, 2010, 16 (08) : 774 - 780
  • [33] High levels of fatty acid synthase expression in esophageal cancers represent a potential target for therapy
    Orita, Hajime
    Coulter, Jonathan
    Tully, Ellen
    Abe, Masaaki
    Montgomery, Elizabeth
    Alvarez, Hector
    Sato, Koichi
    Hino, Okio
    Kajiyama, Yoshiaki
    Tsurumaru, Masahiko
    Gabrielson, Edward
    CANCER BIOLOGY & THERAPY, 2010, 10 (06) : 549 - 554
  • [34] Fatty acid synthase as a novel prognostic biomarker and a potential therapeutic target in diffuse malignant peritoneal mesothelioma
    Doldi, Valentina
    Martini, Silvia
    Ciniselli, Chiara Maura
    Beretta, Alessia
    Deraco, Marcello
    Kusamura, Shigeki
    Baratti, Dario
    Gandellini, Paolo
    Verderio, Paolo
    Zaffaroni, Nadia
    CANCER RESEARCH, 2024, 84 (06)
  • [35] PD-L1 as a potential Therapeutic Target for a Subgroup of mucinous Ovarian Carcinomas with a hypermutated Genotype
    Bartl, T.
    Alberts, A.
    Wolf, A.
    Hofstetter, G.
    Muellauer, L.
    Grimm, C.
    Castillo-Tong, Cacsire D.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (06) : S45 - S45
  • [36] Tumoral and Peritumoral Immune PD-L1 Expression in Ovarian and Endometrial Clear Cell Carcinomas
    Willis, Brian C.
    Sloan, Emily A.
    Mills, Anne
    MODERN PATHOLOGY, 2017, 30 : 314A - 315A
  • [37] Tumoral and Peritumoral Immune PD-L1 Expression in Ovarian and Endometrial Clear Cell Carcinomas
    Willis, Brian C.
    Sloan, Emily A.
    Mills, Anne
    LABORATORY INVESTIGATION, 2017, 97 : 314A - 315A
  • [38] CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
    Kawahara, Naoki
    Yamada, Yuki
    Kobayashi, Hiroshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [39] ONCOGENIC HISTONE METHLTRANSFERASE, WHSC1 IS A PROMISING THERAPEUTIC TARGET IN OVARIAN CLEAR CELL CARCINOMA
    Kojima, M.
    Sone, K.
    Oda, K.
    Kukita, A.
    Machino, H.
    Oki, S.
    Honjyo, H.
    Kawata, Y.
    Tanikawa, M.
    Nagasaka, K.
    Matsumoto, Y.
    Komatsu, M.
    Kaneko, S.
    Hamamoto, R.
    Osuga, Y.
    Fujii, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 739 - 739
  • [40] Insulin growth factor 1 pathway is a potential therapeutic target for low-grade ovarian serous carcinomas
    Wong, K.
    Tsang, Y.
    Zu, Z.
    Mok, S.
    Deavers, M.
    Birrer, M.
    Wolf, J.
    Lu, K.
    Gershenson, D.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S113 - S114
12345